NURO 4.25 (+2.41%)
US6412558073• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. NURO

NeuroMetrix (NURO) Competitor Comparison

We are evaluating the key criteria listed to compare NeuroMetrix (NURO) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

44 / 44

Gross Profits

36 / 40

Total Revenue

39 / 43

EBITDA

30 / 44

Free Cashflow

31 / 44

Quick Ratio

2 / 44

Earnings per Share

41 / 44

Dividend yield

0 / 13

Total Cash

33 / 44

Performance 3 years

43 / 44

Performance 5 years

39 / 44

Performance 10 years

42 / 44

Linearity 3 years

40 / 44

Linearity 5 years

33 / 44

Linearity 10 years

31 / 44

Total Rank

18 / 44

Dividend Rank

29 / 44

Valuation Rank

42 / 44

Piotroski Rank

30 / 44

Muliplier Rank

17 / 44

Linearity 5 years - NURO ranking 33 / 44

These are the competitors of NeuroMetrix in the industry Medical Instruments & Supplies ranked by linearity 5 years
1. Masimo MASI
56.6
2. ICU Medical ICUI
38.98
3. Intuitive Surgical ISRG
27.4
4. Becton, Dickinson BDX
23.8
5. Staar Surgical STAA
19.36
6. NexGel NXGL
18.86
7. iRhythm Technologies IRTC
13.37
8. AtriCure ATRC
11.86
9. Harvard Bioscience HBIO
11.37
10. Envista Holdings NVST
9.71
11. Bausch & Lomb BLCO
9.4
12. KORU Medical Systems KRMD
9.33
13. Haemonetics HAE
6.94
14. Cooper Companies COO
6.76
15. Utah Medical Products UTMD
5.85
16. Ansell PD1.F
5.44
17. OraSure Technologies OSUR
5.13
18. Atrion ATRI
4.9
19. Teleflex TFX
4.77
20. Steris STE
4.72
21. BioLife Solutions BLFS
4.69
22. Pulse Biosciences PLSE
4.67
23. AngioDynamics ANGO
4.46
24. Repligen RGEN
4.34
25. Alcon ALC
4.17
26. Hologic HOLX
4.06
27. ResMed RMD
3.88
28. electroCore ECOR
3.74
29. Baxter BAX
3.51
30. Dentsply Sirona XRAY
3.2
31. NovoCure NVCR
3.15
32. Microbot Medical MBOT
2.65
33. NeuroMetrix NURO
2.63
34. Nephros NEPH
2.45
35. West Pharmaceutical Services WST
2.3
36. Warby Parker WRBY
2.15
37. Akoya Biosciences AKYA
1.9
38. Ekso Bionics Holdings EKSO
1.58
39. Femasys FEMY
1.48
40. Predictive Oncology POAI
1.31
41. Merit Medical Systems MMSI
0.72
42. Glaukos GKOS
0.7
43. Pro-Dex PDEX
0.67
44. LeMaitre Vascular LMAT
0.53
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.